← SynDRA
FLUPHENAZINE DECANOATE
SynDRA canonical compound SYN0023237 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | DRD2 | HTR1B | HTR4 |
| Mechanism of action | dopamine receptor antagonist |
| Indication | schizophrenia |
| Disease area | neurology/psychiatry |
All known targets
Mechanisms of action (all sources)
- DRD2 ANTAGONIST
- Dopamine D2 receptor antagonist
- dopamine receptor antagonist
- HTR1B MODULATOR
Drug classes
- Antipsychotic Agents
- Central Nervous System Agents
- Central Nervous System Depressants
- Psychotropic Drugs
- Tranquilizing Agents
- Dopamine Agents
- Dopamine Antagonists
- Neurotransmitter Agents
- Phenothiazine
Cross-references
Synonyms
- flufenazine decanoate
- fluorophenazine decanoate
- lyogen
- modecate
- prolixin decanoate
- Dapotum d
- Fluphenazini decanoas
- Lyogen
- Moditen depot
- NSC-169510
- QD-10733
- SQ-10733
- Decazate
- Depot
- Modecate
- Modecate conc
- Prolixin decanoate
- Dapotum D
- Flufenazine decanoate
- Fluorophenazine decanoate
- Fluphenaline decanoate
- Fluphenazine depot
- Fluphenazine O-decanoate
- Moditen-depo
- Prolixin decanoate (TN)
- SQ 10,733
- Fluphenazine decanoate (JAN/USP)
- Decanoic acid, 2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]-1-piperazinyl]ethyl ester
- Decanoic acid, 2-[4-[3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl]-1-piperazinyl]ethyl ester
- Decanoic acid, 2-(4-(3-(2-(trifluoromethyl)phenothiazin-10-yl)propyl)-1-piperazinyl)ethyl ester
- Decanoic acid, 2-(4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazinyl)ethyl ester
- 2-(4-(3-(2-(Trifluoromethyl)phenothiazin-10-yl)propyl)-1-piperazinyl)ethyl decanoate
- 2-(4-{3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl}piperazin-1-yl)ethyl decanoate
- 2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethyl decanoate
- fluphenazine enanthate impurity c (ep impurity)
- moditen-depot
- fluphenazine decanoate (ep monograph)
Look up FLUPHENAZINE DECANOATE in the interactive SynDRA portal →